According to Avadel Pharmaceuticals
's latest financial reports the company has $0.10 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $0.10 B | 8.92% |
2022-12-31 | $96.49 M | -38.62% |
2021-12-31 | $0.15 B | -28.99% |
2020-12-31 | $0.22 B | 245.09% |
2019-12-31 | $64.15 M | -35.79% |
2018-12-31 | $99.91 M | 6.21% |
2017-12-31 | $94.07 M | -38.99% |
2016-12-31 | $0.15 B | 6.49% |
2015-12-31 | $0.14 B | 55.98% |
2014-12-31 | $92.83 M | 1219.23% |
2013-12-31 | $7.03 M | -23.13% |
2012-12-31 | $9.15 M | -62.62% |
2011-12-31 | $24.49 M | -21.86% |
2010-12-31 | $31.34 M | -28.87% |
2009-12-31 | $44.06 M | 18.85% |
2008-12-31 | $37.07 M | -9.7% |
2007-12-31 | $41.06 M | -34.58% |
2006-12-31 | $62.77 M | -25.07% |
2005-12-31 | $83.77 M | -20.5% |
2004-12-31 | $0.10 B | -3.87% |
2003-12-31 | $0.10 B | 654.57% |
2002-12-31 | $14.52 M | 173.63% |
2001-12-31 | $5.3 M |
Company | Cash on Hand | differencediff. | Country |
---|---|---|---|
OPKO Health
OPK | $95.88 M | -8.78% | ๐บ๐ธ USA |
Onconova Therapeutics ONTX | $25.24 M | -75.98% | ๐บ๐ธ USA |